• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用聚丙烯腈膜血液透析治疗暴发性肝衰竭

Treatment of fulminant hepatic failure by polyacrylonitrile-membrane haemodialysis.

作者信息

Silk D B, Trewby P N, Chase R A, Mellon P J, Hanid M A, Davies M, Langley P G, Wheeler P G, Williams R

出版信息

Lancet. 1977 Jul 2;2(8027):1-3. doi: 10.1016/s0140-6736(77)90001-0.

DOI:10.1016/s0140-6736(77)90001-0
PMID:69100
Abstract

24 patients with fulminant hepatic failure who had deteriorated to grade-IV coma were treated by repeated periods of haemodialysis with a polyacrylonitrile membrane. 9 patients fully recovered consciousness, and 8 (33%) survived to leave hospitals. These results are to be compared with those of conservative management alone (15% survival in 53 cases) and those obtained initially with charcoal haemo-perfusion (38%). Of the 16 treatment failures, cerebral oedema was found at necropsy in 13 (18%). Whether this would have been less of problem if treatment had been started earlier in the course of the illness remains to be determined.

摘要

24例暴发性肝衰竭且已恶化为Ⅳ级昏迷的患者接受了使用聚丙烯腈膜的反复血液透析治疗。9例患者完全恢复意识,8例(33%)存活出院。这些结果将与单纯保守治疗的结果(53例中15%存活)以及最初使用活性炭血液灌流获得的结果(38%)进行比较。在16例治疗失败的患者中,尸检发现13例(18%)有脑水肿。如果在疾病过程中更早开始治疗,这是否会成为一个较小的问题仍有待确定。

相似文献

1
Treatment of fulminant hepatic failure by polyacrylonitrile-membrane haemodialysis.用聚丙烯腈膜血液透析治疗暴发性肝衰竭
Lancet. 1977 Jul 2;2(8027):1-3. doi: 10.1016/s0140-6736(77)90001-0.
2
Polyacrylonitrile membrane dialysis for hepatic coma.
Lancet. 1977 Aug 27;2(8035):451-2.
3
Treatment of encephalopathy during fulminant hepatic failure by haemodialysis with high permeability membrane.采用高通透性膜血液透析治疗暴发性肝衰竭中的肝性脑病。
Gut. 1978 Sep;19(9):787-93. doi: 10.1136/gut.19.9.787.
4
[Hemodialysis with a high permeability membrane in the treatment of encephalopathy of fulminant hepatitis].
Ann Fr Anesth Reanim. 1987;6(5):423-8. doi: 10.1016/s0750-7658(87)80368-4.
5
Experiences in the treatment of fulminant hepatic failure by conservative therapy, charcoal haemoperfusion, and polyacrylonitrile haemodialysis.保守治疗、活性炭血液灌注和聚丙烯腈血液透析治疗暴发性肝衰竭的经验。
Int J Artif Organs. 1978 Jan;1(1):29-33.
6
High-permeability membrane hemodialysis and hemofiltration in acute hepatic coma: experimental and clinical results.
Artif Organs. 1979 Nov;3(4):354-60. doi: 10.1111/j.1525-1594.1979.tb01077.x.
7
Plasma amino acid profiles in patients with fulminant hepatic failure treated by repeated polyacrylonitrile membrane hemodialysis.
Gastroenterology. 1978 Dec;75(6):1033-40.
8
[Artificial hepatic support device with polyacrylonitrile (PAN) membrane, with special reference to hemodiafiltration].
Nihon Rinsho. 1982;40(4):890-6.
9
[Encephalopathy in acute hepatic atrophy. Effect of the purification of middle molecules. Preliminary results].[急性肝萎缩中的脑病。中分子物质纯化的作用。初步结果]
Nouv Presse Med. 1975 Dec 6;4(42):2987-91.
10
Artificial liver support in fulminant hepatic failure.暴发性肝衰竭中的人工肝支持
Bull N Y Acad Med. 1975 Apr;51(4):508-18.

引用本文的文献

1
Prognosis of acute-on-chronic liver failure patients treated with artificial liver support system.人工肝支持系统治疗慢性重型肝炎患者的预后
World J Gastroenterol. 2015 Aug 28;21(32):9614-22. doi: 10.3748/wjg.v21.i32.9614.
2
Cerebrospinal fluid drainage and cranial decompression prolong survival in rats with fulminant hepatic failure.脑脊液引流和颅骨减压可延长暴发性肝衰竭大鼠的生存期。
Transpl Int. 2006 Aug;19(8):675-82. doi: 10.1111/j.1432-2277.2006.00322.x.
3
Successful treatment of refractory cerebral oedema in ecstasy/cocaine-induced fulminant hepatic failure using a new high-efficacy liver detoxification device (FPSA-Prometheus).
使用新型高效肝脏解毒装置(FPSA-普罗米修斯)成功治疗摇头丸/可卡因所致暴发性肝衰竭中的难治性脑水肿
Wien Klin Wochenschr. 2003 Sep 15;115(15-16):599-603. doi: 10.1007/BF03040456.
4
Extracorporeal perfusion for the treatment of acute liver failure.用于治疗急性肝衰竭的体外灌注
Ann Surg. 2000 Apr;231(4):460-70. doi: 10.1097/00000658-200004000-00003.
5
Clinical experience with a bioartificial liver in the treatment of severe liver failure. A phase I clinical trial.生物人工肝治疗严重肝衰竭的临床经验。一项I期临床试验。
Ann Surg. 1997 May;225(5):484-91; discussion 491-4. doi: 10.1097/00000658-199705000-00005.
6
Clostridium difficile infection of the gut.肠道艰难梭菌感染
J Clin Pathol. 1996 Jul;49(7):529-32. doi: 10.1136/jcp.49.7.529.
7
Development of a hybrid bioartificial liver.一种混合生物人工肝的研发。
Ann Surg. 1993 May;217(5):502-9; discussion 509-11. doi: 10.1097/00000658-199305010-00010.
8
Development of reliable artificial liver support (ALS)--plasma exchange in combination with hemodiafiltration using high-performance membranes.可靠的人工肝支持(ALS)的发展——使用高性能膜的血浆置换联合血液透析滤过。
Dig Dis Sci. 1993 Mar;38(3):469-76. doi: 10.1007/BF01316501.
9
Gall stone recurrence and its prevention: the British/Belgian Gall Stone Study Group's post-dissolution trial.胆结石复发及其预防:英国/比利时胆结石研究小组的溶石后试验。
Gut. 1993 Sep;34(9):1277-88. doi: 10.1136/gut.34.9.1277.
10
A bioartificial liver to treat severe acute liver failure.一种用于治疗严重急性肝衰竭的生物人工肝。
Ann Surg. 1994 May;219(5):538-44; discussion 544-6. doi: 10.1097/00000658-199405000-00012.